---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-025269"
form_type: "8-K"
ticker: "GTBP"
cik: "0000109657"
company_name: "GT Biopharma, Inc."
filed_at: "2024-06-26T23:59:59+00:00"
generated_at: "2026-06-01T01:19:47.769157+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# GT Biopharma annual meeting elects all four directors, ratifies auditor

## Summary
- Quorum: 691,084 shares (50.05%) represented at June 25 annual meeting.
- All four directors elected: Breen (298,002 for), Shrotriya (295,782), Wendel (229,004), Casamento (266,456).
- Ratification of Weinberg & Company as auditor: 579,726 for, 89,595 against, 21,763 abstain.
- Non-binding advisory vote on executive compensation approved: 277,591 for, 47,062 against, 6,392 abstain, 360,039 broker non-votes.

## SEC filing metadata
- accession: 0001493152-24-025269
- form_type: 8-K
- ticker: GTBP
- cik: 0000109657
- company_name: GT Biopharma, Inc.
- filed_at: 2024-06-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/109657/000149315224025269/0001493152-24-025269-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/109657/000149315224025269/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-025269
- JSON: https://secwatch.observer/filing/0001493152-24-025269.json
- Plain text: https://secwatch.observer/filing/0001493152-24-025269.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.